PMID: 7537395Apr 27, 1995Paper

Transgenic expression of human complement regulatory proteins in mice results in diminished complement deposition during organ xenoperfusion

Transplantation
K R McCurryJ L Platt

Abstract

Complement activation is an essential step in the hyperacute rejection of a vascularized xenograft. Endothelial cell-associated complement regulatory proteins limit complement activation in most settings, but are not able to limit the extensive complement activation that occurs in xenografts, at least in part due to their species specificity. To overcome this problem we and others have sought to express human complement regulatory proteins in the organs of potential donor animals. As an initial step toward evaluating this concept we tested organs from transgenic mice expressing human CD59 and/or decay-accelerating factor (DAF) in two in vitro perfusion systems for the ability to control activation of heterologous complement. In the first system, mouse hearts were perfused on a Langendorff circuit with 50% human plasma. Immunopathologic analysis of heart biopsies revealed deposition of human IgG, IgM, and C4 in both control and transgenic organs. The hearts from mice transgenic for human CD59 had substantially less and in some cases no membrane attack complex (MAC) and hearts from CD59/DAF transgenic mice had substantially less or no C5b and MAC. In the second system, mouse hearts were perfused with baboon blood through arterial...Continue Reading

Citations

Aug 11, 2000·Transplantation Proceedings·M G van DixhoornF Grosveld
Dec 26, 2001·Transplantation Proceedings·S ChenF Z Sun
Aug 14, 2003·Molecular Immunology·Daniel Turnberg, Marina Botto
May 2, 2002·Journal of Hematotherapy & Stem Cell Research·Sally AraiGeorgia B Vogelsang
Feb 22, 2008·Journal of Gastroenterology and Hepatology·Prabhleen ChahalKeith D Lindor
Feb 22, 2008·Journal of Gastroenterology and Hepatology·Simone I Strasser
Jul 5, 2005·Expert Opinion on Investigational Drugs·L E Diamond
Apr 28, 1997·Biochemical and Biophysical Research Communications·S MiyagawaM Okabe
Nov 16, 2004·Anesthesiology Clinics of North America·Zain KhalpeyJeffrey L Platt
Feb 26, 2004·The American Journal of Pathology·Soheyla SaadiJeffrey L Platt
Jun 1, 2005·Drug Discovery Today·David A DunnDavid L Kooyman
Feb 9, 2002·Molecular Reproduction and Development·Hiroshi MurakamiTaroh Kinoshita
Nov 18, 2003·Immunological Reviews·A M James ShapiroJonathan R T Lakey
May 29, 2007·Arthritis and Rheumatism·David M CauviK Michael Pollard
Apr 1, 2003·Nature Biotechnology·Yoshihiro Miyata, Jeffrey L Platt
Mar 2, 2019·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Steven C KimAndrew B Adams
Jun 10, 2003·Annals of the New York Academy of Sciences·Johan van BeekPhilippe Gasque

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.